PULMODOX 5 % PREMIX

Pays: Irlande

Langue: anglais

Source: HPRA (Health Products Regulatory Authority)

Ingrédients actifs:

DOXYCYCLINE HYCLATE

Disponible depuis:

Virbac S.A.

Code ATC:

QJ01AA02

DCI (Dénomination commune internationale):

DOXYCYCLINE HYCLATE

Dosage:

5 %w/w

forme pharmaceutique:

Premix for Med.Feedstuffs

Type d'ordonnance:

POM

Groupe thérapeutique:

Porcine

Domaine thérapeutique:

Doxycycline

indications thérapeutiques:

Antibacterial

Statut de autorisation:

Authorised

Date de l'autorisation:

2001-01-12

Résumé des caractéristiques du produit

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
PULMODOX 5 % PREMIX
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
EACH GRAM CONTAINS
ACTIVE SUBSTANCE(S)
Doxycycline
............................................................. 50 mg
(as hyclate form)
EXCIPIENTS
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Premix for medicated feeding stuff.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs (after weaning).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Prevention of clinical
respiratory disease due to_ Pasteurella multocida_ and_ Mycoplasma
hyopneumoniae_ sensitive to
doxycycline_._ The presence of disease in the herd should be
established before treatment
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substance or to
any of the excipients.
Do not use in animals with hepatic dysfunction.
See section 4.7.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The uptake of medication by animals can be altered as a consequence of
illness.
In case of insufficient
feed intake,
animals should be treated parenterally
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_8_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_6_
_3_
_1_
_3_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Inappropriate use of the product may increase the prevalence of
bacteria resistant to tetracycline due to the potential for
cross resistance.